Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Income from Continuing Operations (2020 - 2025)

Maravai Lifesciences Holdings has reported Income from Continuing Operations over the past 6 years, most recently at 63015000.0 for Q4 2025.

  • Quarterly results put Income from Continuing Operations at 63015000.0 for Q4 2025, down 36.79% from a year ago — trailing twelve months through Dec 2025 was 230762000.0 (up 11.12% YoY), and the annual figure for FY2025 was 230762000.0, up 11.12%.
  • Income from Continuing Operations for Q4 2025 was 63015000.0 at Maravai Lifesciences Holdings, down from 45057000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for MRVI hit a ceiling of 156721000.0 in Q2 2022 and a floor of 172455000.0 in Q3 2024.
  • Median Income from Continuing Operations over the past 5 years was 13522500.0 (2023), compared with a mean of 16557700.0.
  • Biggest five-year swings in Income from Continuing Operations: soared 9227.12% in 2021 and later tumbled 1582.49% in 2024.
  • Maravai Lifesciences Holdings' Income from Continuing Operations stood at 127111000.0 in 2021, then plummeted by 31.22% to 87429000.0 in 2022, then crashed by 225.8% to 109982000.0 in 2023, then soared by 58.11% to 46067000.0 in 2024, then crashed by 36.79% to 63015000.0 in 2025.
  • The last three reported values for Income from Continuing Operations were 63015000.0 (Q4 2025), 45057000.0 (Q3 2025), and 69837000.0 (Q2 2025) per Business Quant data.